Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115486) titled 'Study on the Pharmaceutical Care Effectiveness of Clinical Pharmacists in Managing the Risk of Acute Kidney Injury Associated with the Combination of Vancomycin and Piperacillin-Tazobactam' on Dec. 26, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Nanjing Drum Tower Hospital
Condition:
Infectious disease
Intervention:
Pharmaceutical care group:From January to December 2026, pharmacists will closely monitor patients who meet the inclusion and exclusion criteria. Based on conventional therapy, clinical pharmacists may optimize drug regimens and provide pharmaceutical care t...